the market?
NuPathe Inc.
NASDAQ: PATH
3.15
-0.01
(-0.32%)
| Today's Open | $3.12 |
|---|---|
| Previous Close | $3.16 |
| Daily Range | $3.12 - $3.17 |
| 52-Week Range | $2.47 - $4.59 |
| Market Cap | $97.9M |
| P/E Ratio | -1.16 |
| Dividend (Yield) | $0.00 (0.0%) |
| Volume | 85,562 |
| Average Daily Volume | 157,833 |
| Current FY EPS | -$1.23 |
How do you think PATH
will perform against the market?
Top PATH Bull/Bear Pitches
zzlangerhans (< 20)
Submitted
June 16, 2011
I caught one bottom on NuPathe last fall and missed another a couple of months ago. Now I'm betting on the stock to rise from the current 100M market cap in advance of the August 29 PDUFA for Zelrix. … More
News & Commentary
5 Reasons Not to Worry This Week
These five companies are going in the right direction on the bottom line.Pre-Market Earnings Report for March 26, 2013 : NEOG, PLCE, PATH
Pre-Market Earnings Report for March 26, 2013 : NEOG, PLCE, PATH5 Reasons Not to Worry This Week
These five companies are going the right way on the bottom line.This Biotech's on the NuPathe to Success
No surprise here; Zecuity gains FDA approval. But, will it sell?NuPathe Shares Jump After US Approves Migraine Patch
Zecuity uses an electrical current to deliver medicine for headache treatment. The product won't hit the market until the fourth quarter, CEO Anido says.Sector
Healthcare
Industry
Drugs
NuPathe Inc. (PATH) Description
NuPathe Inc is abiopharmaceutical company focused on the development and commercialization of branded therapeutics for diseases of the central nervous system including neurological and psychiatric disorders. Website: http://www.nupathe.com/
